Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Dren Bio has raised $25.0M in total funding. The most recent round was Corporate Round. The last funding was announced in July 2024.
Dren Bio's investors include 8VC, Pfizer, Novartis, SR One, Alexandria Venture Investments.
Dren Bio is headquartered in Foster City, United States.
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Dren Bio is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dren Bio — Funding & Investors." VCBacked, July 24, 2024, https://www.vcbacked.co/company/dren-bio. Accessed July 19, 2026.
VCBacked. (2024). Dren Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/dren-bio
{{cite web |title=Dren Bio — Funding & Investors |url=https://www.vcbacked.co/company/dren-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated